i
Osteoporosis: regulatory view.
-
1987 Jul-Aug
By Sobel, SSource: Public Health Rep. 102(4 Suppl):136-139
Details:
-
Alternative Title:Public Health Rep
-
Personal Author:
-
Description:Evaluation of drugs proposed for the prevention and treatment of osteoporosis is difficult. The Food and Drug Administration (FDA) has issued guidelines for the clinical investigation of drugs in this class. Estrogen has been approved for the treatment of postmenopausal osteoporosis. Administration of estrogen requires careful assessment of the risks and benefits for the individual patient. The smallest effective dose should be used. There are both potential risks and benefits for the concommitant administration of a progestin. Calcitonin has also been approved; however, the need for parenteral administration, the problem of antibody formation, and expense may limit the usefulness of the currently marketed preparations. Calcium has been recommended, but because it is considered a food supplement it has not been submitted to FDA for evaluation of its safety and efficacy as a drug in the treatment of osteoporosis. Other drugs under investigation include anabolic steroids, fluorides, vitamin D substances, biphosphonates, parathyroid hormone, and thiazides.
-
Pubmed ID:3120212
-
Pubmed Central ID:PMCnull
-
Document Type:
-
Collection(s):
-
Main Document Checksum:urn:sha256:aa73d2a26c5c741b26bb37641735f98f45780f6072d6bfde67bb37034b3ae852
-
Download URL:
-
File Type:
Supporting Files
-
No Additional Files
More +
Related Documents
-
Personal Author:Jacobson, Howard N.1987 Jul-Aug | Public Health Rep. 102(4 Suppl):50-52Description:Great progress on key issues in maternal nutrition has been made in the past few years, mainly because of the legislative requirements of the U.S. Dep...Personal Author:Crooks, G M1987 Jul-Aug | Public Health Rep. 102(4 Suppl):85-90Description:Public policy is an area of increasing study. Of concern in this presentation is the consensus-building feature of policymaking in the United States. ...Personal Author:Blume, S B1987 Jul-Aug | Public Health Rep. 102(4 Suppl):38-42Description:There are a variety of reasons why women are believed to be more susceptible than men to the effects of alcohol. Physical factors, such as body water ...Personal Author:Johnson, E M1987 Jul-Aug | Public Health Rep. 102(4 Suppl):42-48Description:The prevalence of illicit drug use is higher among men than women, but new drug use occurs at twice the rate for females as for males. Recent data fro...Personal Author:Wingard, D L1987 Jul-Aug | Public Health Rep. 102(4 Suppl):62-67Description:In the United States, women live longer than men, and they have lower death rates at virtually every age and for most causes of death. The sex differe...Personal Author:Newman, D M1987 Jul-Aug | Public Health Rep. 102(4 Suppl):74-77Description:Women can adopt health practices that will help them to maintain good health throughout their various life stages. Women can take charge of their heal...Personal Author:Starck, P L1987 Jul-Aug | Public Health Rep. 102(4 Suppl):81-84Description:The role of the university, and particularly the health sciences university, in promoting positive health for women is twofold. First, the disseminati...Personal Author:Berlin, Cheston M.1987 Jul-Aug | Public Health Rep. 102(4 Suppl):53-54Description:It is a regulatory fact that only 14 drugs are approved for use during pregnancy; none of them is specifically approved for use in nursing mothers. Wi...Personal Author:Liptzin, B1987 Jul-Aug | Public Health Rep. 102(4 Suppl):34-38Description:The number of elderly women is growing in absolute numbers and in proportion to the U. S. population. Current epidemiologic research indicates that th...Personal Author:Woods, N F1987 Jul-Aug | Public Health Rep. 102(4 Suppl):106-112Description:A collection of over 200 symptoms has been labeled premenstrual syndrome. Common belief is that most women experience a marked increase in symptoms pr...Personal Author:Steinberg, Karen K.Jul 1987 | Public Health Rep. 102(4 Suppl):125-127Description:The cause of osteoporosis, a condition in which bone mass is decreased to a point where structural failure may occur, is unknown; many factors that co...Personal Author:Rogers, Paul G.Jul 1987 | Public Health Rep. 102(4 Suppl):141-142Description:A wide range of resources are available to enhance the communication and education of women. The patient's attitude should connote a sense of rights a...Personal Author:Vaitukaitis, Judith L.Jul 1987 | Public Health Rep. 102(4 Suppl):103Description:These discussions will encompass important areas which relate to the pathophysiology of the menstrual cycle. Unfortunately, only a narrow window of th...Personal Author:Williams, T. FranklinJul 1987 | Public Health Rep. 102(4 Suppl):62Description:This important topic, aging, is really a woman's issue as things now stand. Someday, it is to be hoped, it will be more a man's issue as well, but tha...
More +
You May Also Like
Personal Author:
Johnston, C C
1989 Sep-Oct | Public Health Rep. 104(Suppl):75-77
Description:
The best approach to treatment of osteoporosis is prevention of bone loss as discussed elsewhere in this volume. However, some currently approved ther...
Personal Author:
Heaney, R P
1989 Sep-Oct | Public Health Rep. 104(Suppl):36-46
Description:
Involutional bone loss, and the fracture syndromes that are designated "osteoporosis," are multifactorial phenomena. Gonadal hormone deficiency, inade...
Checkout today's featured content at stacks.cdc.gov